NanoMolecularDX, LLC a/k/a NMDX, LLC, MetaboRX, LLC and Patrick Muraca – Goodman & Nekvasil P.A. May Recover Investor Losses
Securities and Exchange Commission Charges NanoMolecularDX, LLC a/k/a NMDX, LLC, MetaboRX, LLC and Patrick Muraca
On July 31, 2017, the Securities and Exchange Commission filed to stop an alleged ongoing fraud by a Massachusetts businessman misusing investments intended for the development of cancer diagnostic tests to instead pay personal expenses and fund his fiancée’s restaurant businesses.
According to the SEC’s complaint, Patrick Muraca established two pharmaceutical development companies and raised nearly $1.2 million by representing to investors that their money would be used to develop products to detect cancer and other diseases. The SEC alleges that it has traced the flow of investor funds into Muraca’s personal bank account and alleges that at least $400,000 has been used to pay rent for the restaurants and fund other purchases by Muraca, including payments to a casino, automotive shop, and cigar shop.
The SEC alleges that investors were never informed of the alternative uses of their investments in NanoMolecularDX LLC and MetaboRX LLC, including the fact that Muraca characterized the general character of the businesses as “Serving Food; Restaurant” in separate documents he has filed with the Commonwealth of Massachusetts to do business in the state.
The SEC obtained a court order freezing the assets of Muraca and his companies.
In a parallel action, the U.S. Attorney’s Office for the Southern District of New York announced criminal charges against Muraca.
Investors in NanoMolecularDX, LLC a/k/a NMDX, LLC and/or MetaboRX, LLC May Recover their Losses with Goodman & Nekvasil, P.A.
If you invested in NanoMolecularDX, LLC a/k/a NMDX, LLC and/or MetaboRX, LLC, Goodman & Nekvasil, P.A. may help you. Goodman & Nekvasil, P.A., a Clearwater, Florida, law firm with a national practice representing victimized investors, has recovered more than $180 million dollars on behalf of victimized investors.
All our cases are handled on a purely contingency fee basis by Kalju Nekvasil, Esq., formerly regional counsel with the NASD, now known as FINRA. Kalju Nekvasil, Esq. has practiced in this area of the law for more than 35 years.
There is no charge for an evaluation of your case. Further, we handle our cases on a contingency fee basis. This means that unless we recover money for you, we charge no attorney’s fee. Unless you recover any money, you pay us nothing, not even the costs and expenses which the firm will advance on your behalf.
If you incurred investment losses in NanoMolecularDX, LLC a/k/a NMDX, LLC and/or MetaboRX, LLC and would like your case evaluated by a securities attorney (again, there is no charge for an evaluation and all cases are handled on a purely contingency fee basis), please contact us.